9 páginas, 4 figuras, 2 tablas.The serine/threonine Pim 1 kinase is an oncogene whose expression is deregulated in several human cancers. Overexpression of Pim 1 facilitates cell cycle progression and suppresses apoptosis. Hence pharmacologic inhibitors of Pim 1 are of therapeutic interest for cancer. ETP-45299 is a potent and selective inhibitor of Pim 1 that inhibits the phosphorylation of Bad and 4EBP1 in cells and suppresses the proliferation of several non-solid and solid human tumor cell lines. The combination of the PI3K inhibitor GDC-0941 with ETP-45299 was strongly synergistic in MV-4-11 AML cells, indicating that the combination of selective Pim kinase inhibitors and PI3K inhibitor could have clinical benefit.Peer reviewe
Pim-1 is a serine/threonine kinase critically involved in the initiation and progression of various ...
The PIM-1 kinase is a serine/threonine kinase that has been implicated in the development of many hu...
Aim: The progression free survival of non-small cell lung cancer (NSCLC) patients has been doubled o...
Human Pim1 (proviral integration site for Moloney murine leukemia virus) kinase is a 313-amino acid ...
PIM Kinase is indeed a serine/threonine protein that is discovered to be overexpressed and functions...
International audienceBACKGROUND Pim family kinases are small constitutively active serine/threonine...
AbstractThe proto-oncogene proviral integration site for moloney murine leukemia virus (PIM) kinases...
PIM kinases have been shown to act as oncogenes in mice, with each family member being able to drive...
Abstract Human Pim1 (proviral integration site for Moloney murine leukemia virus) kinase is a 313-am...
The proviral insertion site in Moloney murine leukemia virus, or PIM proteins, are a family of serin...
The identification as cooperating targets of Proviral Integrations of Moloney virus in murine lympho...
The identification as cooperating targets of Proviral Integrations of Moloney virus in murine lympho...
Pim-1 is a serine/threonine kinase critically involved in the initiation and progression of various ...
The Proviral Integration site of Moloney murine leukemia virus (PIM) serine/threonine protein kinase...
Pim-1 is a serine/threonine kinase critically involved in the initiation and progression of various ...
Pim-1 is a serine/threonine kinase critically involved in the initiation and progression of various ...
The PIM-1 kinase is a serine/threonine kinase that has been implicated in the development of many hu...
Aim: The progression free survival of non-small cell lung cancer (NSCLC) patients has been doubled o...
Human Pim1 (proviral integration site for Moloney murine leukemia virus) kinase is a 313-amino acid ...
PIM Kinase is indeed a serine/threonine protein that is discovered to be overexpressed and functions...
International audienceBACKGROUND Pim family kinases are small constitutively active serine/threonine...
AbstractThe proto-oncogene proviral integration site for moloney murine leukemia virus (PIM) kinases...
PIM kinases have been shown to act as oncogenes in mice, with each family member being able to drive...
Abstract Human Pim1 (proviral integration site for Moloney murine leukemia virus) kinase is a 313-am...
The proviral insertion site in Moloney murine leukemia virus, or PIM proteins, are a family of serin...
The identification as cooperating targets of Proviral Integrations of Moloney virus in murine lympho...
The identification as cooperating targets of Proviral Integrations of Moloney virus in murine lympho...
Pim-1 is a serine/threonine kinase critically involved in the initiation and progression of various ...
The Proviral Integration site of Moloney murine leukemia virus (PIM) serine/threonine protein kinase...
Pim-1 is a serine/threonine kinase critically involved in the initiation and progression of various ...
Pim-1 is a serine/threonine kinase critically involved in the initiation and progression of various ...
The PIM-1 kinase is a serine/threonine kinase that has been implicated in the development of many hu...
Aim: The progression free survival of non-small cell lung cancer (NSCLC) patients has been doubled o...